Conduct in vitro screening of interventional agents in high throughput screening (HTS) formats: high throughput screening to identify HIV inhibitors
Ended Awarded Last action
- Contract number
- 75N93023F00002
- Awardee
-
Research Triangle Institute UEI JJHCMK4NT5N3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $227,601
Award facts
- Opportunity
-
- 75N93023F00003 Solicitation number
- Contract value 100% obligated
- $227,601.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $227,601 |
About this award
This is a $227,601 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Preclinical Services for HIV Therapeutics Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The purpose is to conduct in vitro screening of interventional agents in high throughput screening (HTS) formats to identify HIV inhibitors. The prime contractor is Research Triangle Institute (RTI International), a non-profit research organization. Two subcontractors are involved: Chemdiv, Inc., a for-profit company providing compound libraries, and Imquest Biosciences, Inc., a for-profit preclinical contract research organization. This award is not set aside for any specific business types.
Quick answers
Who was awarded contract 75N93023F00002?
75N93023F00002 was awarded to Research Triangle Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 16, 2023.
How much is contract 75N93023F00002 worth?
The government has obligated $227,601 on 75N93023F00002.
Is contract 75N93023F00002 an order under another contract?
Yes. 75N93023F00002 is a delivery order under 75N93021D00004, an indefinite delivery contract, on Preclinical Services for HIV Therapeutics.
Was contract 75N93023F00002 competed?
The extent of competition for 75N93023F00002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award